http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007532486-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate | 2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007532486-A |
| titleOfInvention | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor |
| abstract | The present invention provides a method of treating or preventing severe pneumonia, which is less than about 1.0 mg / kg / hour in patients with or at risk of having severe pneumonia. Administering TFPI or a TFPI analog by continuous intravenous infusion at a dosage rate equivalent to that of reference ala-TFPI at a dosage rate of 24% of the administration of TFPI or TFPI analog. Have not received anticoagulant within the time. The method preferably involves the use of continuous intravenous infusion of TFPI or TFPI analog at low doses to avoid adverse side effects. |
| priorityDate | 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.